Position in INCY
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$107,108,935
+$39,937,139 QoQ
Shares Held
1,138,004
+67.3% QoQ
Ownership
0.570%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95.7820007662539.ToString("F0")%
Shared 0.ToString("F0")%
None 4.217999233746103.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Derivatives in INCY
reported options exposure · as of Mar 31, 2026CallValue
$210,075
CallShares
2,232
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. INCY ranks #17 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in INCY
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $107,108,935 | 1,138,004 | Shares | Defined | 2026-05-05 | |
| 2026-03-31 | $210,075 | 2,232 | Call | Defined | 2026-05-05 | |
| 2025-12-31 | $67,171,796 | 680,083 | Shares | Defined | 2026-01-29 | |
| 2025-12-31 | $220,454 | 2,232 | Call | Defined | 2026-01-29 | |
| 2025-09-30 | $123,456,387 | 1,455,682 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $92,696,491 | 1,361,182 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $80,220,028 | 1,324,856 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $55,992,906 | 810,669 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $33,251,338 | 503,046 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $27,330,704 | 450,853 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $23,022,260 | 404,112 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $32,780,836 | 522,071 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $22,715,856 | 393,212 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $30,319,359 | 487,058 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $15,615,304 | 216,069 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $37,581,967 | 467,903 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $34,143,468 | 512,357 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $43,479,604 | 572,326 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $233,223,896 | 2,936,589 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $70,710,108 | 963,353 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,564,354 | 240,831 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $12,808,034 | 152,241 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $12,264,942 | 150,916 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $19,667,307 | 226,113 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $10,993,506 | 122,504 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $20,128,798 | 193,602 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $9,668,556 | 132,030 | Shares | Defined | 2020-05-01 | |
| 2020-03-31 | $31,855,050 | 435,000 | Call | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||